After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

The narrative for 2025 is forming fast: low-entry tokens with actual utility and protocol depth are taking center stage. While familiar names like Ethereum (ETH), Solana (SOL), and Chainlink (LINK) ...